146
Participants
Start Date
January 3, 2020
Primary Completion Date
May 28, 2021
Study Completion Date
February 13, 2024
Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg)
Test drug: Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg)
Suvast tablet 10 mg (Rosuvastatin 10 mg)
\- Control drug: Suvast tablet 10 mg (Rosuvastatin 10 mg)
Korea University Ansan Hospital, Ansan
Soon Chun Hyang University Hospital Bucheon, Bucheon-si
Soon Chun Hyang University Hospital Cheonan, Cheonan
Keimyung University Dongsan Medical Center, Daegu
Yeongnam University Medical Center, Daegu
Eulji University Hospital, Daejeon
Kyung Hee University Hosipital at Gangdong, Gangdong
Inje University Ilsan Paik Hospital, Goyang-si
Hanyang University Guri Hospital, Guri-si
Chosun University Hospital, Gwangju
Hallym University Medical Center-Dongtan, Hwaseong-si
Inha University Hospital, Inchon
Pusan National University Hospital, Pusan
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Kyung Hee University Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea, Seoul St.Mary, Seoul
The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul
Yonsei University Health System, Gangnam Severance Hospital, Seoul
Yonsei University Health System, Severance Hospital, Seoul
Gachon University, Donginchoen Gil Hospital, Sŏngnam
Seoul National University Bundang Hospital, Sŏngnam
Ajou University Hospital, Suwon
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Gangnam Severance Hospital
OTHER
Seoul National University Hospital
OTHER